Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ (TAM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Institut Cancerologie de l'Ouest
Sponsor:
Information provided by (Responsible Party):
Institut Cancerologie de l'Ouest
ClinicalTrials.gov Identifier:
NCT01220076
First received: October 11, 2010
Last updated: August 30, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)